Literature DB >> 9780396

Clinical correlates of major depression in Cushing's disease.

N Sonino1, G A Fava, A R Raffi, M Boscaro, F Fallo.   

Abstract

Major depression is a common, life-threatening complication of Cushing's syndrome, with no significant differences between pituitary-dependent and -independent forms. Little is known about the clinical correlates of depression; in particular, whether patients with Cushing's disease and major depression show some clinical features that are distinctive compared to those who are not depressed. The occurrence of major depression according to DSM-IV criteria was ascertained in 162 patients with pituitary-dependent Cushing disease. Major depression occurred in 88 of the patients (54%). It was significantly associated with older age, female sex, higher pretreatment urinary cortisol levels, relatively more severe clinical condition, and absence of pituitary adenoma. Patients with Cushing's disease and depression appeared to suffer from a more severe form of illness, both in terms of cortisol production and clinical presentation, compared to those who were not depressed. Because of these connections, the presence of depression is an important clinical feature that should not be neglected. The findings in this study may have implications for a better understanding of the pathophysiological role of depression associated with medical illness.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9780396     DOI: 10.1159/000029054

Source DB:  PubMed          Journal:  Psychopathology        ISSN: 0254-4962            Impact factor:   1.944


  36 in total

1.  Sense of coherence buffers relationships of chronic stress with fasting glucose levels.

Authors:  J Zhang; P P Vitaliano; S K Lutgendorf; J M Scanlan; M V Savage
Journal:  J Behav Med       Date:  2001-02

Review 2.  Pros and cons of screening for occult Cushing syndrome.

Authors:  Antoine Tabarin; Paul Perez
Journal:  Nat Rev Endocrinol       Date:  2011-03-22       Impact factor: 43.330

Review 3.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

4.  Corticosteroid use in neuro-oncology: an update.

Authors:  Patrick Roth; Caroline Happold; Michael Weller
Journal:  Neurooncol Pract       Date:  2014-10-09

5.  Structural and Functional Consequences of Hypercortisolism on Brain: Are the Brain and Psycho-neuro-cognitive Manifestations Reversible?

Authors:  Mahendra Kumar Garg; Madhukar Mittal
Journal:  Indian J Endocrinol Metab       Date:  2021-01-12

Review 6.  Psychiatric disorders associated with Cushing's syndrome. Epidemiology, pathophysiology and treatment.

Authors:  N Sonino; G A Fava
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 7.  Disruption of fetal hormonal programming (prenatal stress) implicates shared risk for sex differences in depression and cardiovascular disease.

Authors:  J M Goldstein; R J Handa; S A Tobet
Journal:  Front Neuroendocrinol       Date:  2013-12-16       Impact factor: 8.606

Review 8.  Psychosomatic aspects of Cushing's syndrome.

Authors:  Nicoletta Sonino; Francesco Fallo; Giovanni A Fava
Journal:  Rev Endocr Metab Disord       Date:  2010-06       Impact factor: 6.514

9.  Impact of sleep and its disturbances on hypothalamo-pituitary-adrenal axis activity.

Authors:  Marcella Balbo; Rachel Leproult; Eve Van Cauter
Journal:  Int J Endocrinol       Date:  2010-06-09       Impact factor: 3.257

10.  A direct comparison of quality of life in obese and Cushing's syndrome patients.

Authors:  Smita Baid Abraham; Brent S Abel; Domenica Rubino; Tonja Nansel; Sheila Ramsey; Lynnette K Nieman
Journal:  Eur J Endocrinol       Date:  2013-04-15       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.